Bank of New York Mellon Corp Reduces Stock Holdings in Relx Plc $RELX

Bank of New York Mellon Corp reduced its stake in shares of Relx Plc (NYSE:RELX) by 7.1% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 231,780 shares of the technology company’s stock after selling 17,695 shares during the period. Bank of New York Mellon Corp’s holdings in Relx were worth $12,595,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Carnegie Investment Counsel purchased a new stake in Relx during the first quarter worth $16,026,000. Ameriprise Financial Inc. grew its stake in Relx by 8.3% during the 1st quarter. Ameriprise Financial Inc. now owns 3,041,132 shares of the technology company’s stock valued at $154,129,000 after acquiring an additional 234,094 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of Relx by 103.4% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 444,360 shares of the technology company’s stock valued at $22,400,000 after purchasing an additional 225,947 shares during the last quarter. Northern Trust Corp increased its stake in shares of Relx by 9.2% in the 1st quarter. Northern Trust Corp now owns 2,394,097 shares of the technology company’s stock worth $120,686,000 after acquiring an additional 202,509 shares during the last quarter. Finally, Janney Montgomery Scott LLC increased its position in Relx by 304.6% during the second quarter. Janney Montgomery Scott LLC now owns 242,649 shares of the technology company’s stock worth $13,186,000 after purchasing an additional 182,673 shares during the last quarter. Institutional investors and hedge funds own 15.02% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. Wall Street Zen lowered shares of Relx from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Barclays restated an “overweight” rating on shares of Relx in a report on Tuesday, October 7th. Weiss Ratings restated a “buy (b-)” rating on shares of Relx in a report on Thursday, November 13th. Kepler Capital Markets raised Relx from a “hold” rating to a “strong-buy” rating in a research report on Thursday, September 18th. Finally, Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research note on Thursday, September 11th. One investment analyst has rated the stock with a Strong Buy rating and five have issued a Buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy”.

Relx Price Performance

Shares of Relx stock opened at $40.27 on Wednesday. The company has a 50-day moving average of $45.21 and a two-hundred day moving average of $49.52. Relx Plc has a 12-month low of $40.00 and a 12-month high of $56.33. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 2.55.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.